Immune System News and Research

RSS

Beta blockers reverse potentially detrimental genetic changes linked to heart disease

Beta blockers are commonly used world-wide to treat a variety of cardiovascular conditions, such as arrhythmias and heart failure.

30 Jun 2017

Ondek raises capital to develop new treatment for childhood allergy

Ondek, the Australian biotechnology company founded by Nobel Laureate Professor Barry Marshall, today announced it raised A$3.59 million in equity funding from professional and high-net-worth investors to support his work to develop a new treatment for childhood allergy.

30 Jun 2017

FDA authorizes marketing of test to aid in diagnoses of serious cancers

The U.S. Food and Drug Administration today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first agency authorized test for use with flow cytometry to aid in the detection of several leukemias and lymphomas, including chronic leukemia, acute leukemia, non-Hodgkin lymphoma, myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).

29 Jun 2017

CWRU researcher receives major NIH grants to develop microscopic drug-delivery systems

Nicole F. Steinmetz, PhD, George J. Picha Professor in Biomaterials, member of the Case Comprehensive Cancer Center, and Director of the Center for Bio-Nanotechnology at Case Western Reserve School of Medicine, has received two major grants from the National Institutes of Health to develop microscopic drug-delivery systems for patients living with breast cancer, and patients at risk for serious blood clots.

29 Jun 2017

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer Institute researchers.

29 Jun 2017

Proteins impeding antitumor immunity could be 'Achilles heel' of some cancers

By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.

28 Jun 2017

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

Researchers from Case Western Reserve University School of Medicine in collaboration with researchers from Dartmouth Geisel School of Medicine and RWTH Aachen University have adapted virus particles- that normally infect potatoes- to serve as cancer drug delivery devices for mice.

28 Jun 2017

Wyss Institute researchers develop new capture technology for cancer diagnostics

Cancerous tumors are formidable enemies, recruiting blood vessels to aid their voracious growth, damaging nearby tissues, and deploying numerous strategies to evade the body's defense systems.

28 Jun 2017

NUS scientists create probiotic gut-friendly beer with health benefits

Beer lovers may soon have a gut-friendly drink to raise a toast to, thanks to the creation of a novel probiotic sour beer by a team of researchers from the National University of Singapore.

28 Jun 2017

Discovery of T cell exhaustion offers new pathway to more powerful immunotherapies

St. Jude Children's Research Hospital immunologists have discovered how immune cells called T cells become "exhausted" -- unable to do their jobs of attacking invaders such as cancer cells or viruses.

28 Jun 2017

New cranberry derivative could help patients dependent on tube feeding

Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.

28 Jun 2017

Study finds link between upper GI infections and protein implicated in Parkinson’s disease

Acute and chronic infections in a person's upper gastrointestinal tract appear to be linked to Parkinson's disease, say scientists at Georgetown University Medical Center and their collaborators at the National Institutes of Health and other institutions.

28 Jun 2017

Immune System News and Research

Beta blockers reverse potentially detrimental genetic changes linked to heart disease

Ondek raises capital to develop new treatment for childhood allergy

FDA authorizes marketing of test to aid in diagnoses of serious cancers

CWRU researcher receives major NIH grants to develop microscopic drug-delivery systems

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Proteins impeding antitumor immunity could be 'Achilles heel' of some cancers

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

Wyss Institute researchers develop new capture technology for cancer diagnostics

NUS scientists create probiotic gut-friendly beer with health benefits

Discovery of T cell exhaustion offers new pathway to more powerful immunotherapies

New cranberry derivative could help patients dependent on tube feeding

Study finds link between upper GI infections and protein implicated in Parkinson’s disease

American scientists develop bioorthogonal labeling test to assess sialylated glycans in tumor cells

Clinical trial of immunotherapy shows promising results for patients with melanoma brain tumors

Antibiotic resistance: a healthcare emergency?

Chronic lack of sleep reduces cognitive abilities, negatively impacts physical health

New approaches to early detection of Parkinson's disease on the horizon

Immunotherapy found to be smarter, kinder treatment for people with head and neck cancer

Study offers insight into earliest molecular steps that lead to organ rejection

BetterYou vitamin D oral spray highly commended at the Veggie Awards 2017

Immunology eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News